Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Open Innovation for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
PL Intelligence
Reports
Partnering Consulting
Due Diligence
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Due Diligence
Overview
Top Applications
Online Panel Discussions
Request Consultation
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Corporation
Out-licensing

Multiplex Assay for Virus Detection

University of Nebraska Medical Center / UNeMed Corporation
Multiplex PCR based assay for the combined detection and diagnosis of Herpes viruses in patient samples.

Full description

Summary
Herpes viruses including Herpes Simplex (HSV), Cytomegalovirus
(CMV), Varicella Zoster virus (VZV), Human Herpesvirus 6 (HHV6),
and Epstein Barr Virus (EBV) are responsible for the common and
significant viral infections associated with neonatal meningitis
(HSV), adult meningitis (HSV or VZV), shingles (VZV), complications
in solid organ transplant (CMV and EBV) and complications in bone
marrow transplantation (CMV, EBV, HHV6).Researchers at the
University Nebraska Medical Center (UNMC) have developed a
multiplex PCR assay for the combined detection and diagnosis of
many clinically relevant herpes viruses in patient samples. The
assay is quantitative and will both benefit patients as wells as
molecular labs where the number of test for detection will be
decreased. Using PCR assay is less costly then other methods and
has been effectively used since January 1, 2004.


Market Value
Assay can be used for both detection and diagnosis and would
benefit patients and molecular labs worldwide as it can detect
many of the common clinically important Herpes viruses.


Features and Benefits
• Cost effective
• Fewer assays need to be run for diagnosis
• Quantitatively detects a many clinically important viruses
• Detection and diagnosis can be done in one test


Publications
• Josh Levitsky, Alison G. Freifeld, Susan Puumala, Kim
Bargenquast, Penny Hardiman, Catherine Gebhart, Lucy
Wrenshall, Alan Langnas, Andre C. Kalil (2007) Cytomegalovirus
viremia in solid organ transplantation: does the initial viral load
correlate with risk factors and outcomes? Clin Transplant 2007
DOI: 10.1111/j.1399-0012.2007.00778.x

Patent information

Patent Pending - Application Published

(TID - 47)

Type of business relationship sought

UNeMed Corporation offers a variety of licensing options and collaborative development opportunities with the University of Nebraska Medical Center.

Licensing contact

Technology Inquiries
*
Request more information

More information

For more information about the product please visit website.

Company details

University of Nebraska Medical Center / UNeMed Corporation
Technology Marketing and Licensing for The University of Nebraska Medical Center

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Industry sector
Diagnostic
Research tools
Therapeutic target
Infectious diseases

Clients in focus...

Get the Flash Player to see this rotator.

Research Partnership for Due Diligence Execution
Americas Antibody Congress
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us